Who invested in Aerovate Therapeutics?
Aerovate Therapeutics's investors include Atlas Venture, RA Capital Management and Cormorant Asset Management.
Who invested in Aerovate Therapeutics
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$73Mraised across 1 round since 2020, from 1 source
- Latest round
- Series A, $73MAug 2020
- Investors
- 3
The rounds
- Aug 2020Series A$73M
Source recordedSEC filing: $76M sold, first sale Aug 2020
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Aerovate Therapeutics
How much has Aerovate Therapeutics raised?
Aerovate Therapeutics has raised $73M across 1 round since 2020.
When did Aerovate Therapeutics last raise?
Aerovate Therapeutics's most recent round was a Series A of $73M in Aug 2020.
What was Aerovate Therapeutics's biggest round?
Its most recent round, $73M in Aug 2020, is also its largest on record.
Who backed Aerovate Therapeutics first?
Aerovate Therapeutics's first round on record, in Aug 2020, was backed by Atlas Venture, RA Capital Management and Cormorant Asset Management.
What stage is Aerovate Therapeutics at?
Aerovate Therapeutics's latest named round is a Series A, in Aug 2020.
Companies like Aerovate Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.